https://doctransparency.com/doctor/fl/bradenton/stuart-offner-1508950692
Medicare Enrolled

Dr. Stuart Offner, MD

Infectious Disease · Bradenton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6010 POINTE WEST BLVD, Bradenton, FL 34209
9417462711
In practice since 2006 (19 years)
NPI: 1508950692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Offner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Offner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Offner

Dr. Stuart Offner is an infectious disease in Bradenton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Offner performed 73,979 Medicare services across 1,954 unique beneficiaries.

Between the years covered by Open Payments, Dr. Offner received a total of $365 from 8 pharmaceutical and/or device companies across 12 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Offner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 8% volume in FL$ $365 industry payments

Medicare Practice Summary

Medicare Utilization ↗
73,979
Medicare services
Top 8% in FL for infectious disease
1,954
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,894 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Daptomycin antibiotic injection68,000$0$0
Hospital follow-up visit, moderate complexity1,840$63$149
Ceftriaxone antibiotic injection1,352$0$10
Infusion, normal saline solution, 250 cc683$0$11
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less456$49$150
Initial hospital admission, moderate complexity318$104$258
Injection, cefepime hydrochloride, 500 mg296$1$21
Hospital follow-up visit, high complexity292$95$217
Injection, ertapenem sodium, 500 mg202$11$75
Blood draw (venipuncture)195$8$15
Office visit, established patient (20-29 min)131$66$190
Initial hospital admission, high complexity80$138$334
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less51$22$54
Office visit, established patient (30-39 min)39$78$250
Hospital follow-up visit, low complexity26$41$101
New patient office visit (45-59 min)18$128$350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
94.4% medium
4.0% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$365
Total received (2018-2023)
Avg $73/year across 5 years
Bottom 34% in FL for infectious disease
8
Companies
12
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$304 (83.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (16.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$67
2022
$18
2020
$60
2019
$12
2018
$207

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Theravance Biopharma, Inc.
$118
Astellas Pharma US Inc
$60
ABBVIE INC.
$43
Merck Sharp & Dohme LLC
$42
Merck Sharp & Dohme Corporation
$38
Melinta Therapeutics, Inc.
$36
Gilead Sciences, Inc.
$14
Allergan Inc.
$12
Top 3 companies account for 60.8% of total payments
Associated products mentioned in payments ›
AVYCAZ · Baxdela · DIFICID · MAVYRET · VIBATIV · Vabomere · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $0 per 100 Medicare services performed
Looking for a infectious disease in Bradenton?
Compare infectious diseases in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
37
Per 100K population
8.9
County median income
$75,792
Nearest hospital
HCA FLORIDA BLAKE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Offner is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Offner experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Offner performed 68,000 daptomycin antibiotic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Offner receive payments from pharmaceutical companies?
Yes. Dr. Offner received a total of $365 from 8 companies across 12 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Offner's costs compare to other infectious diseases in Bradenton?
Dr. Offner's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Offner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →